[Low-density lipoprotein cholesterol levels and lipid-lowering treatment status among young and middle-aged ultra-high-risk patients with acute coronary syndrome in China].

医学 急性冠脉综合征 内科学 心肌梗塞
作者
J Liu,D Zhao,Y C Hao,N Yang,Z Q Sun,J Liu
出处
期刊:PubMed 卷期号:50 (12): 1161-1168 被引量:1
标识
DOI:10.3760/cma.j.cn112148-20220920-00731
摘要

Objective: To assess low-density lipoprotein cholesterol (LDL-C) levels and use of lipid-lowering treatment among young and middle-aged ultra-high-risk patients with acute coronary syndrome (ACS) in China. Methods: The study was based on the"Improving Care for Cardiovascular Disease in China (CCC)-ACS"project, a collaborative registry by and Chinese Society of Cardiology (CSC) and the American Heart Association. Hospitalized-patients with ACS were consecutively enrolled from 159 tertiary and 82 secondary hospitals across China, related clinical information was collected. This study included young and middle-aged hospitalized patients (18-59 years) with ACS from November 2014 to December 2019 registered in CCC-ACS project. Ultra-high-risk was defined according to Chinese expert consensus on lipid management of ultra-high-risk atherosclerotic cardiovascular disease (ASCVD) patients of CSC. The mean LDL-C levels at admission, pre-hospital lipid-lowering therapy and proportion of patients with LDL-C target achieved were analyzed. Results: A total of 42 230 patients younger than 60 years with ACS were included in this study. The mean age was (50.4±6.9) years, and 86.8% (36 676/42 230) of the ACS patients were male. Among them, 86.9% (36 687/42 230) met the criteria of ultra-high-risk. The mean level of LDL-C at admission was (2.8±1.0)mmol/L, only 5.3 % (1 948/36 687) patients achieved the targeted goal of LDL-C<1.4 mmol/L. Among the ultra-high-risk ASCVD patients, 17.5% (6 430/36 687) received lipid-lowering drugs before hospitalization, 96.4% (6 198/6 430) of whom received statins monotherapy. Among patients receiving pre-hospital statins, only 9.9% (626/6 323) patients reached an LDL-C<1.4 mmol/L at admission. Conclusions: The majority of young and middle-aged hospitalized patients with ACS are ultra-high-risk patients for ASCVD in China. Pre-hospital lipid-lowering drugs use is lower in these ultra-high-risk ASCVD patients and most patients do not reach the new LDL-C target level at admission.目的: 了解中国中青年超高危急性冠状动脉综合征(ACS)患者低密度脂蛋白胆固醇(LDL-C)水平及降胆固醇药物使用现状。 方法: 本研究基于中华医学会心血管病学分会(CSC)和美国心脏协会(AHA)合作的中国心血管疾病医疗质量改善(CCC)项目。该项目在全国159家三级医院和82家二级医院连续入选ACS住院患者,系统收集患者临床相关信息。本研究纳入CCC项目2014年11月至2019年12月入选的中青年(年龄18~59岁)ACS住院患者,根据CSC《超高危动脉粥样硬化性心血管疾病患者血脂管理中国专家共识》超高危患者的界定标准,分析超高危ACS患者LDL-C平均水平及院前接受调脂治疗情况。 结果: 研究共纳入42 230例中青年ACS住院患者,年龄(50.4±6.9)岁,男性86.8%(36 676/42 230)。86.9%(36 687/42 230)的患者符合超高危标准。超高危ACS患者入院时LDL-C水平为(2.8±1.0)mmol/L,仅有5.3%(1 948/36 687)的患者达到1.4 mmol/L的目标值。超高危患者中,17.5%(6 430/36 687)的患者院前服用调脂药物,其中96.4%(6 198/6 430)的患者采用他汀单药治疗。接受他汀治疗的超高危患者中,9.9%(626/6 323)的患者LDL-C<1.4 mmol/L。 结论: 中青年ACS住院患者中绝大多数属于超高危,需要采用更低的LDL-C降脂治疗目标。超高危患者院前较少服用降胆固醇药物,大部分患者入院时LDL-C水平高于推荐的目标值且距目标值的差距较大。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
打打应助fyj采纳,获得30
刚刚
蒋瑞轩发布了新的文献求助10
2秒前
今后应助儒雅魂幽采纳,获得10
2秒前
W查查发布了新的文献求助10
2秒前
ziyewutong完成签到,获得积分10
3秒前
思源应助loey采纳,获得10
3秒前
4秒前
Yolo完成签到 ,获得积分10
4秒前
彭于晏应助柳叶刀小猪采纳,获得10
4秒前
钱罐罐发布了新的文献求助10
5秒前
5秒前
高山我梦发布了新的文献求助10
6秒前
ASBL完成签到,获得积分10
7秒前
蒋瑞轩完成签到,获得积分10
8秒前
Steven发布了新的文献求助10
8秒前
123456完成签到,获得积分10
8秒前
风华正茂完成签到,获得积分10
9秒前
orixero应助钱罐罐采纳,获得10
10秒前
doudou发布了新的文献求助30
11秒前
12秒前
16秒前
16秒前
高大的易蓉发布了新的文献求助100
17秒前
18秒前
情怀应助博士采纳,获得10
18秒前
小火苗发布了新的文献求助10
18秒前
23秒前
24秒前
HMethod完成签到 ,获得积分10
24秒前
24秒前
量子星尘发布了新的文献求助10
25秒前
25秒前
25秒前
山东及时雨完成签到,获得积分20
25秒前
27秒前
W查查完成签到,获得积分10
27秒前
yuk发布了新的文献求助30
28秒前
yyp发布了新的文献求助30
28秒前
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976107
求助须知:如何正确求助?哪些是违规求助? 3520330
关于积分的说明 11202435
捐赠科研通 3256819
什么是DOI,文献DOI怎么找? 1798504
邀请新用户注册赠送积分活动 877642
科研通“疑难数据库(出版商)”最低求助积分说明 806496